BellBrook Labs announced today that they have been awarded a fourth U.S. patent for their innovative line of Transcreener® HTS Assay kits. This new patent, U.S. 7,847,066, describes the invention of a ...

Eliminating fucose could improve prospects for development-stage drugs through some combination of reducing toxicity while increasing activity. Applications from early discovery through manufacturing.